Skip to main content
OpenTrials
Completed

NCT Number: NCT06672744

Superior Cluneal Nerve Entrapment Syndrome, Kinesiotaping and Myofascial Release Techniques

Myofascial release techniques and/or kinesiotaping may be effective in the treatment of superior cluneal nerve impingement syndrome ?

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Konya Beyhekim Training and Research Hospital

Konya, Selçuklu, 42060, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients diagnosed with superior cluneal nerve entrapment syndrome

Exclusion criteria

  • those with communication problems
  • those who also described pain in the mid-lumbar region

Treatment and study plan

Exercise

Other

Lumbar muscles (especially quadratus lumborum) and thoracolumbar fascia stretching exercises and strengthening exercises for the lumbar and abdominal muscles were described by the physiotherapist. Participants were asked to perform the exercises three times a day, five days a week

Other names: stretching exercises, strengthening exercises

Myofascial Release Technique

Other

Myofascial release technique was applied by the same researcher (YY) twice a week for four weeks.

Kinesiotaping

Other

Kinesiotaping was performed by the same researcher (XX) for two sessions per week for four weeks with fascia correction technique

Primary outcomes

  1. Visual Analoque Scale

    Time frame: Before treatment, immediately after treatment, 1 month after the end of treatment

    Visual Analoque Scale is a scale consisting of a single 10 cm line and assesses the intensity of pain. Patients were asked to rate the level of pain after being informed that the beginning point on the scale represented no pain and the end point represented the most excruciating pain they had ever experienced

  2. The Roland-Morris Disability Questionnaire

    Time frame: Before treatment, immediately after treatment, 1 month after the end of treatment

    The Roland-Morris Disability Questionnaire is a questionnaire developed to assess functional disabilities in patients with low back pain [15]. In the questionnaire consisting of 24 sentences about functional disabilities, patients are asked to answer each sentence as yes if it fits their situation and no if it does not. Yes answers are calculated as '1' and no answers as '0' points, resulting in a total score between 0-24, with a higher score indicating more disability.

Secondary outcomes

  1. SF-36 Quality of Life Scale

    Time frame: Before treatment, immediately after treatment, 1 month after the end of treatment

    SF-36 Quality of Life Scale is a general quality of life scale frequently used in clinical research. The scale consists of 36 items, which measure 8 different dimensions: physical functions, social functions, role inhibition due to physical problems, physical pain, mental health, role inhibition due to emotional problems, life energy, general health perception. The subscales assess health on a scale of 0 to 100, with higher scores indicating good health quality.

Sponsors and collaborators

Lead sponsor

Savaş Karpuz

Other Gov

Registry information

Official study title

Comparison of the Efficacy of Kinesiotaping and Myofascial Release Techniques in the Treatment of Superior Cluneal Nerve Entrapment Syndrome: A Randomised Single Blind Controlled Trial

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Nov 4, 2024
Registry last updated
Nov 4, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.